Logo image of CALX

CALIX INC (CALX) Stock Fundamental Analysis

NYSE:CALX - New York Stock Exchange, Inc. - US13100M5094 - Common Stock

39.1  +1.18 (+3.11%)

Fundamental Rating

4

Taking everything into account, CALX scores 4 out of 10 in our fundamental rating. CALX was compared to 51 industry peers in the Communications Equipment industry. CALX has an excellent financial health rating, but there are some minor concerns on its profitability. CALX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CALX had positive earnings in the past year.
In the past year CALX had a positive cash flow from operations.
CALX had positive earnings in 4 of the past 5 years.
CALX had a positive operating cash flow in each of the past 5 years.
CALX Yearly Net Income VS EBIT VS OCF VS FCFCALX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

The Return On Assets of CALX (-1.96%) is better than 60.78% of its industry peers.
CALX has a better Return On Equity (-2.37%) than 60.78% of its industry peers.
Industry RankSector Rank
ROA -1.96%
ROE -2.37%
ROIC N/A
ROA(3y)13.29%
ROA(5y)8.42%
ROE(3y)17.35%
ROE(5y)10.5%
ROIC(3y)N/A
ROIC(5y)N/A
CALX Yearly ROA, ROE, ROICCALX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

1.3 Margins

In the last couple of years the Profit Margin of CALX has declined.
CALX's Operating Margin has declined in the last couple of years.
The Gross Margin of CALX (50.94%) is better than 68.63% of its industry peers.
CALX's Gross Margin has improved in the last couple of years.
CALX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.94%
OM growth 3Y-32.39%
OM growth 5YN/A
PM growth 3Y-23.05%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.19%
CALX Yearly Profit, Operating, Gross MarginsCALX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

9

2. Health

2.1 Basic Checks

CALX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CALX has been reduced compared to 1 year ago.
CALX has more shares outstanding than it did 5 years ago.
CALX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CALX Yearly Shares OutstandingCALX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CALX Yearly Total Debt VS Total AssetsCALX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

CALX has an Altman-Z score of 10.35. This indicates that CALX is financially healthy and has little risk of bankruptcy at the moment.
CALX has a better Altman-Z score (10.35) than 94.12% of its industry peers.
CALX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.35
ROIC/WACCN/A
WACC9.76%
CALX Yearly LT Debt VS Equity VS FCFCALX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

CALX has a Current Ratio of 4.50. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CALX (4.50) is better than 86.27% of its industry peers.
CALX has a Quick Ratio of 3.73. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.73, CALX belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.5
Quick Ratio 3.73
CALX Yearly Current Assets VS Current LiabilitesCALX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CALX have decreased strongly by -41.10% in the last year.
The Earnings Per Share has been growing by 17.73% on average over the past years. This is quite good.
CALX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.68%.
Measured over the past years, CALX shows a quite strong growth in Revenue. The Revenue has been growing by 18.69% on average per year.
EPS 1Y (TTM)-41.1%
EPS 3Y17.73%
EPS 5YN/A
EPS Q2Q%-71.11%
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y24.31%
Revenue growth 5Y18.69%
Sales Q2Q%-23.84%

3.2 Future

Based on estimates for the next years, CALX will show a decrease in Earnings Per Share. The EPS will decrease by -4.63% on average per year.
Based on estimates for the next years, CALX will show a decrease in Revenue. The Revenue will decrease by -2.20% on average per year.
EPS Next Y-66.72%
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%
EPS Next 5YN/A
Revenue Next Year-20.18%
Revenue Next 2Y-9.27%
Revenue Next 3Y-2.2%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CALX Yearly Revenue VS EstimatesCALX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CALX Yearly EPS VS EstimatesCALX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.47 indicates a quite expensive valuation of CALX.
Based on the Price/Earnings ratio, CALX is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CALX to the average of the S&P500 Index (28.29), we can say CALX is valued expensively.
With a Price/Forward Earnings ratio of 55.95, CALX can be considered very expensive at the moment.
CALX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.44. CALX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 45.47
Fwd PE 55.95
CALX Price Earnings VS Forward Price EarningsCALX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CALX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 50.76
EV/EBITDA N/A
CALX Per share dataCALX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as CALX's earnings are expected to decrease with -4.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CALX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIX INC

NYSE:CALX (1/22/2025, 2:35:05 PM)

39.1

+1.18 (+3.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)01-29 2025-01-29/amc
Inst Owners90.48%
Inst Owner Change-0.08%
Ins Owners10.22%
Ins Owner Change-0.35%
Market Cap2.59B
Analysts78.46
Price Target45.73 (16.96%)
Short Float %4.65%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.32%
Min EPS beat(2)37.25%
Max EPS beat(2)41.39%
EPS beat(4)3
Avg EPS beat(4)21.83%
Min EPS beat(4)-7.62%
Max EPS beat(4)41.39%
EPS beat(8)7
Avg EPS beat(8)20.51%
EPS beat(12)11
Avg EPS beat(12)20.24%
EPS beat(16)15
Avg EPS beat(16)27.18%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-3.04%
Min Revenue beat(4)-5.05%
Max Revenue beat(4)-1.83%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.53%
PT rev (1m)0%
PT rev (3m)3.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.87%
EPS NY rev (1m)0%
EPS NY rev (3m)4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 45.47
Fwd PE 55.95
P/S 2.91
P/FCF 50.76
P/OCF 38.16
P/B 3.33
P/tB 3.91
EV/EBITDA N/A
EPS(TTM)0.86
EY2.2%
EPS(NY)0.7
Fwd EY1.79%
FCF(TTM)0.77
FCFY1.97%
OCF(TTM)1.02
OCFY2.62%
SpS13.42
BVpS11.74
TBVpS9.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.96%
ROE -2.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.94%
FCFM 5.74%
ROA(3y)13.29%
ROA(5y)8.42%
ROE(3y)17.35%
ROE(5y)10.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-32.39%
OM growth 5YN/A
PM growth 3Y-23.05%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.19%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 87.65%
Cap/Sales 1.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.5
Quick Ratio 3.73
Altman-Z 10.35
F-Score5
WACC9.76%
ROIC/WACCN/A
Cap/Depr(3y)91.78%
Cap/Depr(5y)92.34%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.89%
Profit Quality(3y)60.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.1%
EPS 3Y17.73%
EPS 5YN/A
EPS Q2Q%-71.11%
EPS Next Y-66.72%
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y24.31%
Revenue growth 5Y18.69%
Sales Q2Q%-23.84%
Revenue Next Year-20.18%
Revenue Next 2Y-9.27%
Revenue Next 3Y-2.2%
Revenue Next 5YN/A
EBIT growth 1Y-171.71%
EBIT growth 3Y-15.96%
EBIT growth 5YN/A
EBIT Next Year-58.82%
EBIT Next 3Y4.54%
EBIT Next 5YN/A
FCF growth 1Y140.46%
FCF growth 3Y-4.14%
FCF growth 5YN/A
OCF growth 1Y101.69%
OCF growth 3Y3.05%
OCF growth 5Y73.67%